FIELD: medicine, cardiovascular surgery in particular.
SUBSTANCE: invention relates to medicine, in particular cardiovascular surgery and angiology. The level of soluble endothelial protein C receptors (sEPCR) and the activity of clotting factor FVIII are determined in the peripheral venous blood of the patient. Then, the presence or absence of type 2 diabetes is assessed. Based on the obtained data, the indicator is calculated according to the original formula. After that, using the obtained z value, the probability of developing restenosis is calculated according to the original formula.
EFFECT: method makes it possible to predict the development of restenosis of the arterial reconstruction zone within a year after the intervention.
1 cl, 2 ex
Authors
Dates
2021-06-22—Published
2020-12-30—Filed